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S54
ABSTRACT Straw men play a major role in the debate over racial disparity in
American medicine. Most have been deployed by the disparities-denying right, but
progressives intent on “outing” racism have sent forth their share.This essay flushes out
the straw men while attempting to understand the competing moral premises that drive
the politics of health care disparity.At bottom, arguments about the scope of disparity
and discrimination in medical care are disputes about the appropriate scope of personal
responsibility for life circumstances. Further research into the factors that correlate with
racial differences in health care can shed light on the circumstances that bring about
these differences.Whether these circumstances, once understood, should be deemed ac-
ceptable is a moral and political matter, and sharp differences over the scope of personal
and public responsibility for these circumstances are inevitable. Such disagreements,
however, distract us from efforts to reach common ground solutions to agreed-upon
inequities in health care.
RICHARD EPSTEIN CHARACTERIZES the Institute of Medicine report onracial disparities (Smedley, Stith, and Nelson 2003) as both a “genteel guilt
trip” and “a determined effort to make things appear worse than they really are”
(Epstein 2005). Since the politics of race are hardly genteel, I shall take this as a
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compliment.1 The IOM report has become a subject of much sound and fury.
Critics on the right have attacked the authors’ motives, condemned the authors
for being too quick to diagnosis discrimination, and insisted that racial disparity
in health care remains unproven. Some on the left, meanwhile, have criticized
the IOM for failing to diagnosis pervasive racism in American medicine.
Allegations of racism attract attention, and the charge that America’s physi-
cians are biased against blacks and Latinos has drawn considerable press cover-
age. But disparities-denying conservatives have found welcoming audiences in
high places. Last year, top officials at the Department of Health and Human Ser-
vices ordered HHS researchers to strike the term disparity from a Congres-
sionally mandated annual report on—“health care disparities” (Bloche 2004).
Officials told the researchers to delete their conclusion that racial disparities are
“pervasive in our healthcare system” and to remove findings of disparity in care
for cancer, cardiac disease, AIDS, asthma, and other illnesses. The researchers
complied. Two days before Christmas, HHS Secretary Tommy Thompson
released a neutered rewrite, one that rejected the IOM’s findings of racial dis-
parity and dismissed the “implication” that racial “differences” in care “result in
adverse health outcomes” or “imply moral error . . . in any way.”
Unhappy HHS officials then leaked earlier versions of the report. Irate House
and Senate Democrats insisted that Thompson retract the rewrite and issue the
researchers’ suppressed version in its stead. In February 2004,Thompson did so,
telling a Congressional hearing that the rewrite had been a “mistake.” This, in
turn, disappointed disparities-deniers, who chided Thompson for failing to
maintain a stand against political correctness.
All sides in this debate have deployed straw men, though the disparities-deny-
ing right has assembled them in greater numbers. I will devote some effort in
this essay to flushing them out. But my larger aim is to understand the ire.To this
end, I will search for the competing moral premises that inspire conflict over
whether racial disparities in health care are a problem and what the state should
do about them.At bottom, I contend, arguments about the scope of disparity and
discrimination in medical care are disputes about the appropriate scope of per-
sonal responsibility for life circumstances. Further research into the factors that
correlate with group differences in health care can shed light on the circum-
stances that bring about these differences. But whether these circumstances, once
understood, should be treated as unjust or inevitable (or even as a matter of just
dessert) is a moral and political matter.Those wedded to an ethic of individual
responsibility and self-reliance, unleavened by sensitivity to unlucky life circum-
stances, differ sharply from those more concerned with fair distribution of life’s
possibilities and misfortunes.
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Straw Men
Straw men heavily populate the essay by Sally Satel and Jonathan Klick in this
issue, and they make their presence felt in Richard Epstein’s piece. Some exam-
ples follow.
Insurance Coverage and Ability to Pay
At the outset, Satel and Klick (2005) portray the IOM report as emphasizing
“discrimination” and underplaying access to quality care as a cause of racial dis-
parities. Epstein does the same. But the IOM report begins by noting that access,
in the form of insurance coverage, is the main determinant of racial differences
in care, since the quality and extent of coverage vary by race (Smedley, Stith, and
Nelson 2003).The IOM Committee on Racial and Ethnic Disparities directed
its attention elsewhere at Congress’s request. The legislation that created the
Committee (and led to its report) instructed the IOM to “Assess the extent of
racial and ethnic differences in health care that are not otherwise attributable to
known factors such as access to care (e.g., ability to pay or insurance coverage)”
(emphasis added), and to “Evaluate potential sources of racial and ethnic dispar-
ities in health care, including the role of bias, discrimination, and stereotyping at
the individual (provider and patient), institutional, and health system levels.”
Thus the Committee sought to factor out differences in insurance coverage,
income, wealth, and other access-related influences, and to focus on racial and
ethnic disparities among patients with similar coverage and ability to pay. The
Committee recognized that racial and ethnic disparities, though substantial, are
small by comparison to differences between the care that insured and uninsured
Americans receive.The panel also noted that health status—as opposed to health
care—disparities mostly reflect differences in behavioral risks, social and eco-
nomic circumstances, and environmental conditions. Medical care by itself has
surprisingly small effects on population-wide health.
Uncertainty and Discretion
Epstein, Satel, and Klick erect another straw man by misportraying the IOM
Committee’s explanation for racial disparities in care that persist after insurance
and other access-related factors are taken into account. Epstein writes that the
Committee’s report “lumps together the questions of clinical uncertainty and
communication breakdown with bias and prejudice,” and evinces “eagerness to
find (illicit) discrimination as the source of the various difficulties.” Satel and
Klick make similar claims.They thereby fail to engage, let alone rebut, the Com-
mittee’s explanation.
The Committee’s explanation invokes two kinds of uncertainty: that arising
from incomplete information about diagnostic and therapeutic alternatives, and
that stemming from shortcomings in doctor-patient communication (Balsa et. al.
2003).The first, in my view, is the most important. Clinical judgment is beset by
pervasive uncertainty about diagnosis and prognosis, the efficacy of tests and
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treatments, and patient preferences (Wennberg 1985). More often than not, med-
ical decisions don’t rest solidly on scientific evidence and physicians choose from
among multiple clinical alternatives.Wide variations in medical practice ensue,
leaving doctors with a great deal of clinical discretion.To the extent that physi-
cians exercise this discretion in ways that vary by race or ethnicity in the aggre-
gate, racial and ethnic differences in heath care ensue. Among the many factors
that can influence the exercise of discretion are race-linked heuristics, attitudes,
and levels of empathy.The cognitive psychology literature contains ample proof
that race-linked heuristics, attitudes, and differences in empathy persist. To be
sure, as John Wennberg and others note, other influences, including geography,
affect the exercise of discretion (Baicker, Chandra, and Skinner 2005). But some
of these influences may themselves be race-linked: patterns of housing segrega-
tion, for example, mean that the effects of geography and race can be correlated,
mutually reinforcing, and difficult to disentangle.
Epstein, Satel, and Klick heap invective on this line of reasoning instead of
probing its recesses. They might have posed questions, not addressed in the
IOM’s report, about when race-linked heuristics should merit deference (on
clinical or other grounds) and when they should be rejected as offensive or inac-
curate stereotypes.They also might have explored the trade-offs between gains
from reducing clinical discretion (and group disparities in care) by imposing
rules and the clinical advantages of bedside discretion. In addition, they could
have examined the role of patients—their expressed preferences and levels of
trust—in shaping physicians’ clinical judgments.
Uncertainty stemming from shortcomings in doctor-patient communication
gets more sympathetic treatment from Epstein than from Satel and Klick. Epstein
is open to the possibility that communication failure matters and that cultural
and linguistic gaps make it more likely. Satel and Klick speak mockingly of a
“‘cultural competence training’ industry,” and they misportray the IOM’s discus-
sion of linguistic and cultural gaps as a diatribe against racial bias. The IOM’s
hypothesis concerning shortcomings in doctor-patient communication is, in
essence, this: (1) communication is imperfect (due to time limits, economic con-
straints, and ambiguities in the meaning of language and other cues); (2) com-
munication across racial and ethnic lines is especially prone to errors and uncer-
tainty because of language and cultural gaps; (3) physicians are therefore more
uncertain about minority group members’ medical needs and concerns; and (4)
physicians are therefore less inclined to offer at least some high-intensity, high-
cost treatments to minority group members. As a corollary, patients separated
from their doctors by language and cultural gaps are more uncertain about the
quality and reliability of their doctors’ recommendations. Faced with this greater
uncertainty, these patients are (on rational grounds) less inclined to agree to rec-
ommended treatments or to seek medical consultation in the first place.
This account of physician-patient communication explains racial disparity, to
some degree, at least, without invoking racial bias. Satel and Klick refuse to ac-
American Medicine and the Politics of Race
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knowledge this; Epstein allows for the possibility but doesn’t pursue its policy
implications. These implications are straightforward. Approaches that Satel and
Klick ridicule, including cultural competence-building and better representation
of disadvantaged minority groups in the health professions, hold out great poten-
tial to shrink race- and ethnicity-related gaps in doctor-patient communication.
So does physician payment reform that better rewards effort spent talking and
listening to patients. Even skeptics about the import of racial bias have reason to
support these approaches as part of an effort to ameliorate health care dispari-
ties. For some on the right, however, ideological blinders get in the way.
Variations in Clinical Circumstances
Yet another straw man, proffered by Epstein, Satel and Klick, and others, is the
claim that the IOM Committee failed to acknowledge that legitimate, race-
related differences in care can arise from variations in clinical circumstances. Dif-
ferences in disease incidence, drug metabolism, treatment efficacy, patient pref-
erences, and family support systems sometimes correlate with race. Good,
patient-centered clinical decision making should take such factors into account,
even if they result in race-related variation.The IOM report took note of this.
Epstein, Satel, and Klick could have pushed the discussion forward in this
sphere by challenging the IOM and others to do better at distinguishing between
clinical differences that do and do not justify racially disparate treatment.There
are gray zones in this realm, worthy of further exploration. One is patient pref-
erences. Conventional bioethics thinking holds that the choices of mentally com-
petent patients merit great deference. But it is well known that these choices are
greatly influenced by how doctors frame and portray clinical alternatives. They
are also shaped by patients’ social circumstances, including community-wide lev-
els of trust.To the extent that these influences themselves reflect race-related un-
fairness, formulaic deference to patient choice cannot be the whole answer. But
how should health policy—and the law—address disparities that arise from these
influences? The role of family support systems raises similar issues.To the extent
that weaker social support systems in minority communities ensue from histori-
cal injustice, medical decision making that takes account of available social sup-
port may be both clinically appropriate and morally problematic. This conun-
drum of health policy and social justice merits deeper exploration.
Minority Physicians’ Beliefs and Attitudes
Epstein, Satel, and Klick also err by assuming that minority physicians are not
influenced by stereotypes or bias when they care for patients who belong to their
own racial or ethnic group.This premise plays a key role in their critique: based
on it, they contend that proof of racial bias in clinical decision making requires
a showing that white and minority physicians treat minority patients differently.
This assumption is understandable—the notion that black or Latino doctors can
hold negative stereotypes or biased attitudes toward their compatriots is coun-
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terintuitive. But evidence from cognitive psychology studies shows that mem-
bers of minority groups often hold unfavorable beliefs and biases toward fellow
group members.A variety of mechanisms for this have been proposed, including
incorporation of ideas and attitudes that prevail in the wider society and identi-
fication with members of favored groups (and with their beliefs and biases). Both
of these mechanisms may be especially relevant for minority physicians anxious
about their social status and eager for acceptance by their white peers. If minor-
ity physicians share their white peers’ beliefs and biases toward minority group
members, then requiring proof that they treat minority (or white) patients dif-
ferently than do white physicians makes no sense.
Discrimination and Racism
The claim that health care disparities are the product of pervasive racism is a
caricature promoted, for the purpose of ridicule, by the disparities-denying
right. Some, though, have invoked the IOM report as proof of pervasive racism
in medicine, and a few press reports have characterized the IOM’s conclusions
in such terms. In fact, the IOM report avoided the word racism, and many have
criticized this omission as a failure to fully acknowledge racial injustice and its
causes. Overt racism—apartheid beliefs (consciously experienced and acted-
upon) about the relative respect and regard owed to whites and to racial minor-
ity groups—is part of the health care disparities equation: it persists on the
fringes in American life. But it is not the main plotline.
There is little evidence that American physicians, as a group, openly harbor
and act upon race-based hatred or contempt. There are outlier cases of crude
bigotry, but preoccupation with these distracts attention from the larger story.
Clinical uncertainty and discretion, race-related heuristics and attitudes, and
communication failures across cultural and linguistic lines interact in complex
ways to create disparity. The word racism is a conversation-stopper—an epithet
that delivers a harsh judgment. Harsh judgment is at times warranted: calling a
bigot a bigot achieves a measure of corrective justice and affirms the human dig-
nity of those who are objects of the bigot’s contempt. But wielding the “r-word”
against race-related heuristics, attitudes, and differences in empathy that are both
widespread and subliminal, even subconscious, in America is more likely to
arouse ire than to encourage self-scrutiny and inspire change.To ameliorate dis-
parities, consciousness-raising scrutiny of causal mechanisms will be essential.
Facile resort to the “r-word” makes such scrutiny less likely.
Subsidies and Morals: 
When Are Racial Differences Wrong?
The chief pity of the right’s resort to straw men is that they divert attention from
conservatives’ more potent objection to policies aimed at ameliorating racial dis-
parities in care. Part of the foundation for the conclusion that disparities are
American Medicine and the Politics of Race
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widespread is the large number of studies that find disparities after controlling
for insurance status, income, education levels, and other confounding factors. Ep-
stein, Satel, and Klick attack this foundation by pointing to potential confound-
ing influences that go unobserved (and uncorrected for) in these studies. Racial
disparities, they note, appear to narrow as additional confounding variables are
identified and factored out.They extrapolate from this argument to the conclu-
sion that unobserved variables, associated with race, explain all apparent racial
disparities. Decisions by doctors and patients, Epstein argues, take myriad unob-
served costs and benefits into account. Because some of these correlate with
race, race-related differences in care ensue.
For Epstein, all racial differences in care that result from differential costs and
benefits are legitimate per se. Some accuse him of thereby countenancing racism.
His response is that markets select against racial prejudice to the point of extin-
guishing it. Racist sellers charge more than non-racists to serve members of the
racial out-group, since racist sellers seek compensation for the affront to their
bigoted tastes. But this price difference, Epstein holds, is the racists’ undoing,
since it channels patrons to cheaper, non-racist sellers.Well-functioning markets,
Epstein says, provide immunity against racial animus, and in medicine, markets
function well enough. Excessive government regulation, not bigotry, keeps mar-
kets from fulfilling their antiracist potential.
This is an appealing story.The American Way, with a few right turns, prevails
over the bigots in the end. Dismissing this account as racist, as some do, is a resort
to epithet, not reason. Epstein’s story, though, sidesteps an anomaly at the outset.
This anomaly points the way to a deeper problem, unacknowledged by those at
either pole of the disparities debate.
The anomaly is that open racism—segregation, exclusion, and race-based
contempt—was pervasive in American life at a time of comparative laissez faire.
Racial segregation and exclusion in economic life, including medicine (Smith
1999), was a matter of choice, not just Jim Crow law. Sellers of myriad goods and
services, including health care, chose to sacrifice profits in order to discriminate
openly.2 The emergence of antidiscrimination laws and antiracist social norms
during the 1960s and 1970s coincided with the intensification of economic and
health and environmental regulation more generally.This is not to say that such
regulation accounts for the fade of overt racism since the 1950s; it is merely to
note that markets made room for racial animus for much of our history.
Does this disprove Epstein’s account? To the contrary, it shows that Epstein
hasn’t pushed his story far enough. His central claim is that race-related differ-
ences in behavior, including health care disparities, result from race-related dif-
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ferentials in costs and benefits. But he hesitates to “count” bigotry as a basis for
cost—the psychic cost bigots experience from treating members of disfavored
groups with equal respect. Epstein is not a racist, and he treats bigotry as an ille-
gitimate preference; this buttresses his wishful thinking about the ability of mar-
kets to extinguish bigoted behavior. By not “counting” bigoted preferences—and
the psychic costs of violating them—he clears a path for his claim that racial dis-
parities are legitimate market outcomes that reflect race-related cost differences.
This is a provocative proposition as it stands, but it would turn offensive were
Epstein to “count” racial animus as a preference and to therefore treat bigoted
behavior as the legitimate product of differential costs.To avoid doing so, he dis-
tinguishes (implicitly) between differential costs that do and do not count. For
Epstein, overt bigotry does not count, but, it seems, virtually every other race-
associated factor does.
The problem with this approach is that it fails to explain how lines are to be
drawn between the factors, or costs, that do and do not count. Indeed, Epstein
doesn’t acknowledge the need to draw such lines; instead, he merely ignores the
psychic costs suffered by disappointed bigots whom markets (or law) won’t let
discriminate. But surely these costs are real for the bigots. Deciding not to count
them is a moral and political judgment—one that virtually all of us would agree
upon, but a political choice nonetheless. Likewise, deciding to count other race-
related factors, as Epstein does, and to treat the racial disparities that result from
them as legitimate, is a political judgment.
Others may and do disagree with this judgment. Many different costs, or vari-
ables, can contribute to racially disparate outcomes by influencing people’s mar-
ket choices. Some, as Epstein, Satel, and Klick note, are difficult to observe and
probably have not been accounted for in studies of health care disparities. Ep-
stein could and should have pushed his story further by explaining all racially
disparate results as products of differential costs, then noting the need for polit-
ical choices between acceptable and illegitimate differentials in cost.
Had Epstein done so, he would have had to acknowledge that differential
costs do not make disparate outcomes legitimate per se. Discovery that a previ-
ously unrecognized differential cost, or unobserved variable, contributes to racial
disparity does not in itself shrink the problem of disparity: it sets up the need for
a political and moral judgment as to whether the newly recognized factor should
be accepted as a given or targeted for amelioration.This judgment is often easy
to make. For example, nearly all would agree that a physician’s race-related em-
pathy or dislike is cause for objection and reason for action.3 Likewise, nearly all
would hold that race-correlated differences in disease presentation and drug
metabolism can justify differences in diagnostic and therapeutic strategies. Other
American Medicine and the Politics of Race
winter 2005 • volume 48, number 1 supplement S61
3There might, however, be disagreement over the proper scope and content of government inter-
vention—e.g., over whether government should pursue primarily punitive, educational, or other
approaches.
07/Bloche/Final/S54–67  12/14/04  6:24 AM  Page S61
factors, however, are politically and morally contested. Should race-correlated
differences in family psychosocial support, patient trust, and therapeutic compli-
ance be tolerated or treated as morally unacceptable?4 Answers to such questions
depend on views about social justice. Do past ill treatment of minorities and
present social, cultural, and economic differences create moral duties to address
gaps in family structure and social capital? How much should government in-
trude into the private sphere in order to tackle such problems, and how much
economic redistribution should the state impose? Are trust and compliance, and
their psychological determinants, a state responsibility, perhaps because of past
government failures to address abuses of trust?
Other politically contested factors reflect the differential abilities of white and
disadvantaged minority populations, in the aggregate, to pursue their needs and
wants within health care systems (Bloche 2001).There is evidence that African
Americans are less inclined to press their needs, to complain, and to sue when
health plans and providers disappoint them. The resulting cost differentials for
payers and providers create incentives to deliver more intensive services to
whites. It is, of course, not the case that all whites are more assertive or demand-
ing than all blacks: these cost differentials represent population-wide trends.These
trends, though, are enough to instill expectations in heuristic fashion, and to
make it economically rational for payers and providers to act on these heuristics
by delivering lower levels of care to African Americans. Should the health care
disparities that result be dismissed as matters of personal preference, not public
responsibility? Or should government intervene, in the face of cost differentials,
either to push payers and providers to compensate for African American reti-
cence or to encourage black patients to more vigorously pursue their needs?
Epstein does not acknowledge, let alone address, these and other political
questions about the morality of disparity. He sidesteps such questions by adopt-
ing the principle of actuarial fairness, the premise that differential costs justify
health care disparities per se. He avoids embarrassment by making an exception
for the differential psychic costs that bigots experience on encountering mem-
bers of groups they don’t like, but he doesn’t explain his basis for this exception.
Epstein’s embrace of actuarial fairness sets up his most far-reaching claim: that
government action to ameliorate disparities entails coerced cross-subsidies.Anti-
discrimination laws triggered by disparate racial impact are his paradigmatic case.
To comply with these laws, Epstein notes, actors must incur costs that they oth-
erwise wouldn’t. For example, applying a disparate impact standard to health
plans would press them to ignore the cost differentials (and business opportuni-
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ties) created by race-related differences in patient assertiveness.To the extent that
antidiscrimination law causes plans to act differently than they would were they
free to respond to race-related cost differentials, it creates a cross-subsidy, from
less assertive to more assertive racial groups.
From an actuarial fairness perspective, such cross-subsidies are wrong: differ-
ential costs should be taken as givens, not shifted between groups. But other con-
ceptions of fairness yield different verdicts on intergroup subsidies. Moral objec-
tion to pervasive, race-related disadvantage, in health and other spheres, leads to
refusal to take race-linked cost differentials as givens—and to insistence on cross-
subsidies that arouse Epstein’s ire. Objection to racial disparity in rescue efforts
leads to insistence on equity in health care provision even when disparities in
care do not yield differences in clinical outcomes.5 Objections to socio-eco-
nomic disparity in health or in rescue efforts give rise to calls for other inter-
group subsidy schemes—schemes that overlap considerably but not completely
with programs aimed at racial inequity.
Epstein does not make the case for preferring actuarial fairness to these other
grounds for judging cross-subsidy schemes, nor does he acknowledge the case
against it.The case for actuarial fairness is tied to the value of allowing differen-
tial costs to remain with the groups that incur them.6 Doing so has value when
group members and others can respond meaningfully to these cost signals by
adjusting their behavior in a socially desirable fashion.Auto insurance is the par-
adigmatic example: different rates for drivers with different safety records en-
courage drivers to take care. Actuarial fairness has another, noninstrumental
value: the morality of reciprocity supports leaving higher costs with those who
voluntarily create them. In the health care disparities context, actuarial fairness
yields little of either of these forms of value. Providing disparate levels of care to
people with different levels of social support, trust and assertiveness, expected
likelihoods of compliance with treatment, and ease of communication with clin-
ical caretakers is unlikely to spur improvements in social support, trust and asser-
tiveness, or these other things. And the morality of reciprocity hardly supports
“punishing” disadvantaged minorities for their deficits (actual or perceived) in
these areas by giving them lower levels of medical care. In the health care dis-
parities realm, actuarial fairness is a principle unmoored from its rationale.
American Medicine and the Politics of Race
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Yet Epstein’s core insight—that racial disparities in care reflect differential
costs—retains its power. If Epstein has not taken the next step, toward a way to
distinguish between acceptable cost differentials and those that merit interven-
tion to ameliorate disparities, neither have activists in the campaign against dis-
parities. Some supporters of robust remedial measures treat the disparities that
remain, after income and insurance status are factored out, as wrongful, race-
based discrimination.To do so is to avoid the task of identifying the mechanisms
that contribute to disparity and making political and moral judgments about the
acceptability of disparities arising from each.
Consider, for example, physician reliance on stereotypes, a pejorative term for
heuristics.Heuristic reasoning is unavoidable in all endeavors characterized by un-
certainty and by complexity that exceeds limited information processing capacity
(Todd and Gigerenzer 2000). Medical practice surely qualifies (Bloche 2003).
Heuristics can be wrong, but they are often remarkably accurate—that is, they
yield results close to those produced by more systematic, comprehensive reason-
ing processes.To the extent that race-related differences in patient assertiveness,
treatment compliance, family support systems, and other clinical variables exist,
heuristics that reflect them will be accurate.To put the point more baldly, some
race-related stereotypes are valid.This makes categorical rejection of racial stereo-
types problematic, something civil rights-oriented progressives (including me)
don’t like to think about.7 Saying no to inaccurate racial stereotypes is a simple
matter. Rejecting a valid heuristic makes no sense unless its use—or its result—so
offends that the cost of invoking it outweighs the cognitive efficiencies it yields.
To reject all race-based heuristics as cases of wrongful discrimination is to take
the categorical position that all carry costs greater than their efficiencies. This
forecloses nuanced consideration of what to do when a stereotype is both nox-
ious and valid. Acknowledging this possibility—and the quandary it presents—
does more than open the way for reluctant use of a stereotype that may have
value under particular decision making constraints. It also clears a path for can-
did exploration of the factors that lend validity to the stereotype. Better under-
standing of these factors can, in turn, aid efforts to ameliorate inequities that lie
behind the stereotype.
An illustration is the stereotype that African American patients have more
fragmented family support systems than whites and are therefore less able to sus-
tain the stresses of intensive and disabling treatment courses.This stereotype may
well be incorrect, and even if it is accurate on a population-wide basis, reliance
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on it may be inefficient: a modest effort to learn something about each patient’s
home life may yield better information at minimal cost.To the extent, though,
that it is accurate, it highlights the importance of paying attention to black
patients’ support systems.8 The availability of social support is relevant to the de-
cision to begin a disabling or agonizing course of treatment—even if taking
social support into account yields racially disparate decisions. And sensitivity to
weaknesses in African American family support systems can help clinical care-
takers to take “affirmative action,” case by case, to fill gaps in family support so
all can benefit from vigorous therapies. Beyond this, awareness of the conse-
quences of family breakdown in the medical setting can fuel efforts to strengthen
families through educational opportunity, job creation, high-quality child care
and preschool, and other proven strategies (Moynihan 1986).
Other sources of racial disparity likewise merit closer scrutiny, in order to
learn more about causal mechanisms and to decide which ones do and don’t
merit remedial action. Americans are bound to differ over how to make these
decisions, since we disagree about the proper scope of personal responsibility and
the extent of society’s obligation to address historical and institutional inequities.
But we should have that debate, and it is unhelpful to dismiss those who take a
broad view of personal responsibility and a narrow view of public obligation as
racists or proponents of discrimination.Those, like me, who hold that racial and
other inequities of opportunity are society’s concern should go about the work
of winning over our fellow citizens (especially those who vote) without sug-
gesting that those who see things differently are apologists for bigotry.
Toward Common Ground Solutions
Progress on disparities is possible through programs built on common ground.
There is wide agreement that universal medical coverage would go most of the
way toward eliminating racial disparities in care. Health insurance, like auto in-
surance, should be a personal obligation, though public subsidies will be needed
to make it affordable to all (Calabrese and Rubiner 2004). Required coverage,
moreover, should include services shown to promote health as well as early
detection and treatment of disease. Framing the problem of health care dispari-
ties as more a quality-of-care matter than a civil rights issue would reduce polit-
ical polarization and make health plans and providers less defensive. Clinical out-
comes research and state-of-the-art quality measurement and management
methods can and should target disparities. In the years ahead, market and politi-
cal pressures will push plans and providers to do so, as America’s workforce and
electorate become increasingly multiracial.The same pressures are also likely to
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8It is, of course, also important to pay attention to other patients’ support systems. But if this stereo-
type is accurate, there will be a higher “yield” from inquiring into African American patients’ sup-
port systems.
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encourage more vigorous efforts to bridge cultural and language barriers to com-
munication and to effective use of health systems by disadvantaged Americans.
Yet a key pathology of American politics will remain an obstacle to progress.
Since 1968, the right has fallen into the habit of seeking votes by stoking work-
ing-class racial and cultural resentment. Success at the polls has been addictive.
In national elections, millions of working-class whites vote against their own and
their families’ economic interests, in favor of candidates hostile to federal health,
education, and other opportunity-creating programs.This electoral alchemy has
aligned economically distressed whites with well-off Americans intent on tax
cuts—and against disadvantaged minorities who benefit from programs these
candidates aim to cut.
Were this alliance to fray, tax-slashing politicians (and their wealthy benefici-
aries) would fare less well at the polls. Race and culture are the ties that bind, by
dividing. Hard-pressed whites bitter over black and Latino advantages, real or
perceived, blind themselves to the concerns they and minorities share. From the
right’s perspective, keeping this bitterness alive, and championing it, are impor-
tant. Opposing affirmative action, disputing claims of race-based disadvantage,
and objecting to vigorous antidiscrimination laws send the desired political sig-
nals. Caricaturing concerns about racial disparities in health care and ridiculing
proposed solutions are consistent with this approach. Dispensing with caricatures
in order to search for common ground would depart sharply from it.9
Liberals participate in this polarizing dynamic. Common ground solutions,
especially universal coverage, will require the well-off to sacrifice. For privileged
Americans with progressive politics, it is easier—and certainly cheaper—to take
the side of the “good guys” by speaking out against racial discrimination than it
is to campaign for the large-scale redistribution (through taxes) that universal
coverage would require. For many baby boomer progressives, being liberal on
social and cultural issues (including race) but tight-fisted on fiscal matters has be-
come a point of pride. This means, in practice, strong support for affirmative
action and antidiscrimination law enforcement—and desultory effort, at best, on
behalf of universal coverage and other initiatives that target core inequalities of
opportunity in American life.10 This stance takes on the “bad guys,” and polar-
S66
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9This is not to say that commentators who deny the existence of racial disparities and dispute
claims of racial injustice are consciously pursuing a political strategy.The likelier basis of their posi-
tions is the congeniality between conservative moral premises (in particular, heavy emphasis on
personal responsibility) and political strategy, and the selection (by conservative think tanks, media,
and other institutions with the power to amplify some voices and dismiss others) of spokesmen
who both believe and effectively articulate the requisite message.
10Examples of other such initiatives include equalization of resources per pupil across rich and poor
public school districts (current struggles between liberals and conservatives over such matters as
vouchers and school choice obscure this larger inequality); universal, high-quality preschool; and
intensive mentoring and tutoring programs for children from disadvantaged neighborhoods.
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izes debate, on racial matters while insulating economic privilege against redis-
tributive politics.
The American debate over racial inequity thus has a Kabuki quality. In health
as in other policy spheres, ritualized struggle over the scope of discrimination
and the propriety of race-conscious remedies masks a shared aversion to more
basic, opportunity-creating change. Polarization protects privilege, in part by set-
ting working-class Americans against each other.There is need and possibility for
a new progressive politics—a politics that highlights financially stressed Amer-
icans’ shared needs and tackles inequities of opportunity, but that respects per-
sonal success. Such a politics can yield common ground solutions that go most
of the way toward ending racial disparity in medical care. But the Kabuki poli-
tics of racial polarization will be a daunting obstacle to overcome.
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